It is no secret that the COVID-19 pandemic has had a profound influence on the biotech sector. Both startups and established companies have developed rapid diagnostic kits, medicines, and vaccines. To optimize production, the biotech industry is embracing technologies such as artificial intelligence (AI), data analytics, and automation. A wide range of procedures may be automated with the aid of AI in biotech businesses, allowing them to scale up their operations. For example, biopharma startups employ AI to accelerate medication discovery by screening biomarkers and combing through the scientific literature to identify innovative medicines. Image classification algorithms enable the accurate detection of many characteristics, such as cancer cells from medical scans and crop disease indications from leaf photos.
In addition, entrepreneurs are using deep learning to study microbiomes, screen phenotypes, and generate rapid diagnoses. While the majority of the industry’s attention is still on medicine, biotech startups are developing solutions for everything from food to materials to environmental monitoring. At the moment, biotech trends are accelerating the research in biomanufacturing, bioprinting, synthetic biology and precision medicine, among other forthcoming applications.
On that note, a distinguished panel of CEOs, CIOs, VCs, and other thought leaders from the industry, along with the editorial board of Startup City, has selected the leading biotech solution providers looking to offer their expertise to the widest market possible.
In this edition, we present to you StartupCity’s “Top 10 BioTech Startups in Europe - 2021.”
